GlassScriptPhysician profile
Rick A Robertson
NPI 1063450807
$35,673.47
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $119.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26,439.26 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $6,132.14 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,636.56 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $253.26 | 2019-2020 | |
| Lundbeck LLC | $194.49 | 2019 | |
| Avanir Pharmaceuticals, INC. | $170.29 | 2019 | |
| Shire North American Group INC | $139.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $132.80 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $117.03 | 2019 | |
| Neos Therapeutics, LP | $81.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $74.45 | 2019 | |
| Vanda Pharmaceuticals INC. | $51.48 | 2019 | |
| Jazz Pharmaceuticals INC. | $47.85 | 2019 | |
| Ironshore Pharmaceuticals INC. | $44.02 | 2019-2020 | |
| Bausch Health US, LLC | $35.42 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $31.17 | 2019 | |
| Owp Pharmaceuticals, INC. | $26.57 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.72 | 2019 | |
| Tris Pharma INC | $16.98 | 2019 | |
| Indivior INC. | $14.90 | 2019 | |
| Orexo US, INC. | $13.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.